• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WALGREENS BOOTS ALLIANCE, INC. ANTIBACTERIAL FLEXIBLE FABRIC MEDIUM BANDAGES; TAPE AND BANDAGE, ADHESIVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WALGREENS BOOTS ALLIANCE, INC. ANTIBACTERIAL FLEXIBLE FABRIC MEDIUM BANDAGES; TAPE AND BANDAGE, ADHESIVE Back to Search Results
Device Problem Use of Device Problem (1670)
Patient Problem Contact Dermatitis (4546)
Event Date 04/21/2022
Event Type  Injury  
Event Description
Used (b)(6) brand antibacterial flexible fabric medium (2"x4") bandage with 0.8% benzalkonium chloride (bzk) (antiseptic) on (b)(6) male's cheek to treat abrasion.After 36 hours of wear, and upon removal using soap and water, very severe irritant contact dermatitis was observed with no pain to patient.After approximately 12 hours of rest and left uncovered, the wound location still presented the severe reaction.Pediatric care was then sought.Pediatrician rx cetirizine (zyrtec) to counter reaction.Also noted that subject bandages contained 0.8% bzk while children's bandages by same manufacturer contain 0.1% bzk as possible source of irritation.Wound location continues to heal 7 days after last use/removal of bandage, with observable improvement in first 24 hours.Fda safety report id # (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ANTIBACTERIAL FLEXIBLE FABRIC MEDIUM BANDAGES
Type of Device
TAPE AND BANDAGE, ADHESIVE
Manufacturer (Section D)
WALGREENS BOOTS ALLIANCE, INC.
108 wilmot road
deerfield IL 60015
MDR Report Key14257495
MDR Text Key290560674
Report NumberMW5109457
Device Sequence Number1
Product Code KGX
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Unknown
Type of Report Initial
Report Date 04/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Expiration Date12/20/2022
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received04/29/2022
Patient Sequence Number1
Treatment
CETIRIZINE (ZYRTEC)
Patient Outcome(s) Other; Disability;
Patient Age3 YR
Patient SexMale
Patient Weight18 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-